Newsroom | 4832 results

Sorted by: Latest
Radiology
-

Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that President Michael Sardano has been appointed to the additional role of Chief Commercial Officer. In this newly created position, Mr. Sardano will direct the company’s global sales, marketing and commercial strategy across its po...
-

Harrison amplía su liderazgo en IA con el lanzamiento de CT Chest, que ya se utiliza en casi la mitad de las imágenes radiológicas

SÍDNEY--(BUSINESS WIRE)--El proveedor de tecnología de salud líder Harrison.ai anunció hoy el lanzamiento de su solución CT Chest con el marcado CE, una herramienta de IA integral que ayuda a los médicos clínicos en la detección de 167 características radiológicas, entre ellas las que pueden sugerir enfermedades con riesgo de vida, tumores y enfermedades crónicas. Con una de las coberturas más amplias en diagnóstico por imágenes de tórax, Harrison.ai CT Chest identifica cerca de nueve hallazgos...
-

Harrison amplia la sua leadership nel settore IA con il lancio di CT Chest, che ora viene impiegata in quasi la metà delle applicazioni diagnostiche per immagini in radiologia

SYDNEY--(BUSINESS WIRE)--Harrison.ai, azienda leader nel settore della tecnologia sanitaria, oggi ha annunciato il lancio di CT Chest, una soluzione IA completa che ha ricevuto il marchio CE, pensata per assistere gli operatori clinici nell’individuazione di 167 caratteristiche radiologiche, comprese quelle potenzialmente indicative di condizioni pericolose per la vita, tumori e malattie croniche. Grazie a una delle coperture più estese nell’imaging toracico, Harrison.ai CT Chest rileva quasi n...
-

Harrison baut seine Führungsposition im Bereich KI mit der Einführung von CT Chest weiter aus und versorgt nun fast die Hälfte der radiologischen Bildgebung

SYDNEY--(BUSINESS WIRE)--Der führende Anbieter von Gesundheitstechnologie, Harrison.ai, gab heute die Markteinführung seiner CE-zertifizierten CT-Brustkorblösung bekannt, einem umfassenden KI-Tool, das Ärzte bei der Erkennung von 167 radiologischen Merkmalen unterstützt, darunter solche, die auf lebensbedrohliche Erkrankungen, Tumore und chronische Krankheiten hindeuten können. Mit einer der umfassendsten Abdeckungen in der Brustbildgebung identifiziert Harrison.ai CT Chest nahezu 9 kritische B...
-

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine today announced third quarter 2025 financial results and provided a business update....
-

TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance

DENVER--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announces financial results for the quarter ended September 30, 2025, and provides an operation update. “TriSalus continued to deliver strong commercial performance in the third quarter, underscoring the growing clinica...
-

NavJam LLC Announces Exclusive Global Distribution Partnership with Ruthless Spine

LOS ANGELES--(BUSINESS WIRE)--NavJam grants exclusive worldwide sales/distribution to Ruthless Spine to market NavJam’s patented and patent-pending spinal surgery instruments....
-

Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

BOSTON--(BUSINESS WIRE)--Clairity today announced the closing of a $43 million Series B financing....
-

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (“MASLD”) and metabolic dysfunction associated steatohepatitis (“MASH”), today announced a significant step in its digital asset strategy with the commencement of staking its holdings of HYPE, the native token of the Hyperliquid ecosystem. This strategic move, guided by AR...
-

Harrison Expands AI Leadership With CT Chest Launch, Now Powering Nearly Half of Radiology Imaging

SYDNEY--(BUSINESS WIRE)--Harrison.ai today announced the launch of its CE-marked CT Chest solution....